Background: To the best of our knowledge, no study has yet focused on the association between the adenoid hypertrophy (AH) and the thiol-disulphide balance.
INTRODUCTION
Pediatric upper airway obstruction is majorly caused by adenoid hypertrophy (AH). The most common clinical manifestations of AH include breathing through the mouth, blockage in nasal airways, speech with a nasal voice and obstructive sleep apnea. These patients are also at high risk for developing chronic sinusitis and middle ear infection (1) . As the airways are congested, the patient may experience sleep deprivation or snoring, and sleep apnea. The manifestations are more severe for the pediatric cases, where the congested airways may lead to chronic sleep apnea and hypoxia. In more severe cases, the patient may develop pulmonary hypertension together with unilateral heart failure (majorly right-sided) (2, 3) . There may be hypoxic metabolic changes in the cellular level; that include dissolution of cellular compartments (including the lysosomes), which leads to the discharge of free oxygen radicals.
In the homeostatic state, the human body can stabilize the free radical formation by producing antioxidants (4) . There are several suggested mechanisms for oxidative stress (OS) formation. They include increased formation of ROS (reactive oxygen species) and free radicals, and diminished ability to manage the oxidative stress. As the radicals are very unstable reactants, they are likely to cause injury to the tissue by reacting with the cellular molecules such as proteins, nu-DOI: 10 Original article cleic acids, fats (specifically in the cell membrane), and carbohydrates. The purpose of antioxidant production is to prevent the possible negative effects of the free radicals. If they are not counterbalanced, the radicals may cause extensive damage, various diseases, or even death (5-9). The thiol-disulfide homeostasis is one of the major mechanisms to prevent OS in the body (9) . An automated process is used for the measurement of the thiol and disulfide levels (individually or cumulatively). With the help of this new method, the thiol-disulfide homeostasis can easily be used as an indicator of OS. The literature reports several different disorders that are associated with the thiol/disulfide balance (10-15); however, there are no studies that have examined its association with AH. Therefore, this study was planned to investigate the association of the thiol/disulfide homeostasis with AH, through the aforementioned newly developed method. The study will mainly focus on the thiol-disulfide and pediatric AH cases. The study includes the application of several other indicators such as total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), ferric reducing/ antioxidant power (FRAP), glutathione (GSH), lipid hydroperoxide (LOOH) and advanced oxidation protein products (AOPP)¹ in order to correctly determine the OS among the subjects.
MATERIAL AND METHODS

The Study Sample
The study was conducted in accordance with the principles of the Declaration of Helsinki, applicable regulatory requirements and Good Clinical Practices. This study was approved by the Ethical Committee of the Hospital (17-11-13 ). An informed consent form was obtained from the parents of the participants prior to being included in the study.
The study was conducted in a non-randomized and prospective manner. The experimental group (AH) consisted of 25 subjects that were chosen among the patients of the Otolaryngology Outpatient Clinic of the Hospital (7 females and 18 males; mean age, 5.20 ± 1.70 years). The control group (C) consisted of 24 healthy children without sleep related complaints and AH (using flexible endoscopy) that were chosen to match the study group regarding gender and age (7 females and 17 males; mean age 5.25 ± 1.75 years).
The subject's airways were transnasally/transorally examined with a flexible endoscope. Following the endoscopic examination, the subjects were graded according to the blockage in the choanal space as follows: Grade 1, 25% blockage; Grade 2, 25 to 50% blockage; Grade 3, 50 to 75% blockage; Grade 4, 75 to 100% blockage. The subjects in the experimental group had Grade 3 or 4 adenoid hypertrophy, and all of these subjects underwent transoral cold curettage adenoidectomy (with general anesthesia). The exclusion criteria were as follows: presence of nasal septal deviation, sinonasal infection, hematological disease, chronic inXammatory diseases, major craniofacial abnormalities, chromosomal syndromes, previous adenotonsillectomy or adenoidectomy; and taking any kind of medication two weeks prior to the study.
Blood sample collection
Blood samples were collected between 8 and 10 a.m. Ten milliliters of venous blood was collected from all participants into vacuum biochemistry tubes. The blood samples were centrifuged for 10 minutes at 4000 rpm; after waiting for 30-45 minutes, the sera were separated and stored at -80°C in Eppendorf tubes until analysis.
Measurement of the Parameters The thiol-disulfide assay
The modified Ellman reagent was used to determine the total thiol content of the samples. The dynamic disulfide amount was calculated as follows: Š(total thiol content-native thiol content)/2¹. The disulfide/thiol ratio was calculated by the obtained results as stated by Erel and Neselioglu (16) .
The glutathione (GSH) assay
The glutathione (GSH) level was assessed through its reaction with OPA (1mg/ml o-phthaldialdehyde in methanol) as per the modified technique of Koyuncu et al. (17) . The obtained GSH level was used as a benchmark. The samples were assessed via the microplate reader (Spectra max M5, USA), with excitation at 345 nm and emission at 425 nm. The results were expressed in nmol/mL (for the serum) and nmol/g (for the wet tissue).
Ferric Reducing Antioxidant Power (FRAP) Assay
The FRAP assay is a colorimetric method that measures the ferric-reducing ability of the plasma. It is easily determined through a computerized method, which makes it a practical indicator of "antioxidant power". In an acidic medium, ferric ions are reduced to ferrous form, leading to the formation of a colored ferrous-tripyridyltriazine complex (18) . In the FRAP assay, the antioxidants are used as reducing agents against Fe(III). The ferric tripyridyltriazine complex ŠFe(III), colorless¹ is reduced to ferrous-(2,4,6-tripyridyl-s-triazine)2 ŠFerrous(II), blue¹. Subsequently, the color change is quantitatively measured through spectrophotometry at 593 nm. The absorption values are positively correlated with the antioxidant power of the sample. Thus, the FRAP assay can be used to quantitatively measure the reducing/antioxidant power of a given sample. A mixture of 1000 mL (100 mL of sample + 900 mL of diluted water) was prepared and mixed with 2 mL of FRAP reagent. After being thoroughly mixed, the mixture was kept in dark for 30 min. It was subsequently analyzed with a spectrophotometer at 593 nm. The following formula was used to calculate the FRAP value: FRAP value mM = ŠAbs. (sample) × FRAP value of Std (mM)¹ / Abs. of Std.
Assay of advanced oxidation protein products
The advanced oxidation protein products (AOPP) were spectrophotometrically determined through a modified version of the Witko, Nguyen, and Descamps-Latscha method (19) . Samples were prepared as follows: 100 mL of supernatant was diluted with phosphate-buffered saline (1:5), 5 mL of 1.16 M potassium iodide was then added to each tube, followed by 10 mL of acetic acid two minutes later. The new mixture was analyzed with the spectrophotometer at 340 nm (blank reference: 1000 mL of PBS, 50 mL of Potassium Iodide (KI), and 100 mL of acetic acid). The chloramine-T absorbance was linear at 340 nm within the range of 0 mmol/L to 100 mmol/L. AOPP concentrations were expressed as micromoles per liter of chloramine-T equivalent.
Total oxidant status (TOS) Assay
The TOS levels were measured with the fully automated Rel Assay kit (Rel Assay Diagnostics kit, Turkey) and an autoanalyzer (Thermo Scientific Multiskan GO, ThermoFisher Scientific, Vartaa, Finland). The results were expressed in ìmol H2O2 equivalent/L.
Total antioxidant status (TAS) Assay
The TAS measurements were made with the fully-automated RL0031 Rel Assay® kit (Rel Assay Diagnos-tics kit; Mega T2p, Gaziantep, Turkey) and an autoanalyzer (Thermo Scientific Multiskan GO, ThermoFisher Scientific, Vartaa, Finland). The results were expressed in micromolartrolox/L.
Oxidative stress index (OSI) Assay
OSI indicated the degree of OS by comparing the TOS and TAS values. The OSI value was calculated using the following formula: OSI (arbitrary unit) = TOS (ìmol H2O2 Eq/l)/TAS (mmol Trolox Eq/l) × 100 (20) .
Lipid hydroperoxide (LOOH) Assay
Serum lipid hydroperoxide (LOOH) concentrations were spectrophotometrically measured (SpectraMax M5, Molecular Devices, USA) using automated iron oxidation-xylenol orange test (21) .
Statistical analysis
The data were analyzed with SPSS for Windows, version 21.0. Descriptive statistics (mean ± standard deviation, median, interquartile range) were used to interpret the data. The differences between the two groups were analyzed with the student's t-test and the differences between the median values were analyzed with the Mann-Withney U-and the chi-square tests. The qualitative data were analyzed using the Pearson c 2 test and Fisher's exact test. p-value < 0.05 was considered to be statistically significant.
RESULTS
The biochemical values and demographic characteristics of all patients are presented in Table 1 . It was determined that the groups were not significantly different regarding their demographic data (p > 0.05). Compared to the control groups, the AH group's TOS values were higher and TAS values were lower (p < 0.05). Also, the mean OSI, LOOH and AOPP levels were found to be significantly higher among the AH patients (p < 0.05 for all variables). However, the FRAP and GSH values were lower in the AH group (p < 0.05).
The native thiol and total thiol levels were lower and the disulfide levels were higher in the AH group (AH), compared to the control group(C) Šnative thiol = 367.1 ± 47.5 lmol/L (AH) vs 476.9 ± 63.5 lmol/L (C), p < 0.05; total thiol = 412.2 ± 48.3 (AH) lmol/L vs 525.8 ± 64.4 lmol/L (C), p < 0.05; disulfide = 28.67 ± 7.97 lmol/L (AH) vs 20.91 ± 3.83 lmol/L (C), p < 0.05¹. Consequently, the disulfide/native thiol and the disulfide/total thiol ratios were found to be higher for the AH group Šdisulfide/native thiol ratio = 7.96 ± 2.59% (AH) vs 4.44±0.88 % (C), p < 0.05; disulfide/total thiol = 7.05 ± 2.14 % (AH) vs 4.01 ± 0.77% (C), p < 0.05¹. The difference between native thiol/total thiol ratios of the two groups was not statistically significant (p = 0.07).
THE USE OF THE THIOL-DISULFIDE HOMEOSTASIS AS AN INDICATOR OF OXIDATIVE STRESS IN PEDIATRIC...
DISCUSSION
It was observed that the disulfide/native thiol and the disulfide/total thiol ratios were significantly higher among the pediatric AH patients compared to the healthy controls. To the best of our knowledge, this is the first study to show that the thiol/disulfide homeostasis can be used as an indicator of OS among pediatric AH cases.
Thiols are a group of organic compounds with a sulfhydryl group (-SH) that is bound to a carbon (C) atom. The sulfhydryl groups can be oxidated to form disulfide bonds and later be reduced back to thiol groups, thus creating the thiol/disulfide homeostasis. The thiols play an important role in maintaining the oxidative condition of the body. They act as a defense mechanism against the reactive oxygen species that cause oxidative stress. Their other functions include apoptosis, detoxification, antioxidant protection, and regulation of cellular enzymatic activity (16, 22) . Most organs and systems are sensitive to oxidative stress and redox products. Hence, the disturbance of the oxidative balance can lead to pathologies in structural and functional levels. Previously, it was only possible to measure the thiol/disulfide homeostasis. It is currently possible to separately measure both compounds with the Erel & Neselioglu method (16) . Several studies have used this method to evaluate different acute and chronic conditions (6, (9) (10) (11) (12) (13) (14) (15) .
Insufficient thiol levels may lead to several disorders; such as bipolar disorder, atopic dermatitis, cardiovascular disorders, neurological disorders and cancer (9) (10) (11) (12) (13) (14) (15) (23) (24) (25) (26) . Thus, it is important to be able to determine the state of the thiol/disulfide balance.
The current literature indicates that the thioldisulfide homeostasis can be used as an indicator of OS for various otorhinolaryngological diseases. Simsek et al. (27) have applied this method to nasal polyposis patients. Kara et al. (24) have similarly used the disulfide/native thiol and disulfide/total thiol ratios to determine the OS state of pediatric tonsillopharyngitis patients.
It is also used to demonstrate the OS status of pediatric adenotonsillar hypertrophy patients (5) . These studies were used as the basis of our research regarding the application of the said method for the pediatric AH patients. Gul et al. (28) have found that the serum disulfide levels had increased among adult AH patients. This oxidative shift is due to the obstructed airways. Several other studies also indicated that adenoid hypertrophy is positively correlated with OS. There are different possible OS indicators for AH patients. However, the thiol-disulfide homeostasis has not been previously used to evaluate the OS of children with AH. We All variables are showed as n(%) for categorical data or as mean ± SD or median (minimum, maximum) for continuous data with or without a normal distribution, respectively. AH, adenoidal hypertrophy; TAS, total antioxidan status; TOS, total oxidan status; OSI, oxidative stres index; FRAP, ferric reducing/antioxidant power; GSH, glutathione; LOOH, lipid hydroperoxide; AOPP, advanced oxidation protein products.
have found that the children with AH had an increased thiol-to-disulfide ratio, and the OS parameters had significantly increased. It should be noted that the oxidant molecules may interact and affect the measurements. The TOS measurement is required to determine the general OS state of a patient, as it provides more information compared to the antioxidants' individual measurements (29) . Indeed, the TAS measurements are more commonly used compared to individual measurements of antioxidants. In this study, we evaluated TOS, TAS, FRAP, LOOH, AOPP, OS¤ and GSH levels of the experimental (AH) and control (C) groups. It was determined that among AH patients, the OS parameters (TOS, OSI, LOOH and AOPP) had increased and antioxidant parameters had decreased (GSH, TAS, FRAP). This indicates increased generation of free radicals due to increased exposure to external pathogens. These findings indicate the need for adenoidectomy among these patients to prevent OS. If left untreated, OS may lead to various diseases such as diabetes mellitus, cancer, chronic kidney disease and liver disorders.
We should be noted that our study has several limitations: the small sample size and the lack of post-adenoidectomy data. However, the initial post-adenoidectomy findings may not be reliable, as anesthesia and surgical treatment lead to operational stress. This leads to short-term changes in the OS status of the patient (30). It is also certain that the direct effects of the surgical procedure, together with the effects of tissue repair after adenoidectomy, are followed by an acute and long-lasting systemic oxidative stress. Nevertheless, the inXuence of this treatment could not be estimated as the oxidative parameters were not measured immediately after adenoidectomy. However, the samples should be collected at a later point during follow-up. Another limitation of study was the lack of information on the severity of the sleep disordered breathing.
Polysomnographic evaluation can be difficult in small children and the correlation between the severity of the sleep disordered breathing and OS parameters in small children is limited.
CONCLUSION
It was determined that the AH patients had decreased thiol and increased disulfide levels compared to healthy controls. Increased oxidative stress may cause serious disorders in children with AH. The thiol-disulfide homeostasis can be used as an easy method to determine the OS status of patients. These initial findings should be confirmed through further prospective studies with larger samples.
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The work received no external financial support. Materijal i metode: U studiju je uklju~eno 25 pacijenata, koji su le~eni u ambulanti otorinolaringologije u na{oj bolnici, a koji su bolovali od adenoidne hipertrofije. Kontrolna grupa je me~ovana prema polu i godinama`ivota, a brojala je 24 zdrava deteta. Ispitivali smo efekat adenoidne hipertrofije na balans tiol-disulfida. Tako|e smo ispitivali ukupni antioksidativni status (UAS), ukupni oksidativni status (UOS), indeks oksidativnog stresa (OSI), redukuju}a/antioksidativna snaga gvo`|a (FRAP), glutation (GSH), lipidnu hidroperoksidazu (LOOH) i produkte vi{ih oksidativnih proteina (AOPP) prilikom odre|ivanja OS statusa kod dece.
Licensing
Rezultati: UOS je bio statisti~ki zna~ajniji u AH grupi, kao i UAK koji je bio statisti~ki zna~ajno vi{i u kontrolnoj grupi (p < 0,05). Srednja vrednost OSI, LO-OH i AOPP bile su statisti~ki zna~ajno vi{e u AH grupi u odnosu na kontrolnu grupu (p < 0,05). Nativni tiol a i ukupni nivoi tioldisulfida bili su vi{i u AH grupi u odnosu na kontrolnu grupu (p < 0,05). Disulfidni nivoi, odnos disulfid/nativni tiol, kao i disulfid/ukupni tiol odnos je bio statisti~ki zna~jano vi{i u AH grupi u odnosu na svoju kontrolnu grupu (p < 0,05).
Zaklju~ak: U zaklju~ku mo`emo ista}i da smo u ovoj studiji dobili rezultate koji ukazuju na sni`en nivo tiola, kao i pove}an nivo disulfidnih vrednosti kod dece sa AH u odnosu na svoje kontrole. Tiol/disulfid homeostaza mo`e biti indikator oksidativnog stresa kod dece sa AD.
Klju~ne re~i: tiol-disulfid balas, adenoidna hipertrofija, oksidativni stres.
